AMBOSS Newsroom - Press Releases

March 25, 2025

AMBOSS closes €240M financing round

AMBOSS, the leading resource for medical education and clinical decision-making in Germany and the US, closes a €240M financing round with new long-term investors, supporting the exploration of additional international markets and the expansion of its offering to nurses and other health care professionals.

April 25, 2024

AMBOSS Acquires NEJM Knowledge+ from NEJM Group

AMBOSS, the leading clinical resource for residents, proudly announces its recent acquisition of NEJM Knowledge+, a learning and assessment tool for clinicians created by NEJM Group.

April 10, 2024

Check the newest articles and mentions about Amboss.

AMBOSS is a global medical knowledge platform that has fundamentally changed the way medical know-how is acquired and utilized at the point of care. Check how the product is being recognised worldwide

February 23, 2023

Saint James School of Medicine partnered with AMBOSS

Saint James School of Medicine (SJSM) aims to improve student outcomes by partnering with AMBOSS, a medical learning platform designed to help future physicians succeed on exams.

DOWNLOAD OUR APP

The United States Medical Licensing Examination (USMLE®️) is a joint program of the Federation of State Medical Boards (FSMB®️) and the National Board of Medical Examiners (NBME®️). The Comprehensive Osteopathic Medical Licensing Examination (COMLEX-USA®️) is administered by the National Board of Osteopathic Medical Examiners (NBOME®️). Additionally, the National Commission on Certification of Physician Assistants (NCCPA®️) governs the Physician Assistant National Certifying Exam (PANCE®️) and related certifications. ABIM®️ is a registered trademark of the American Board of Internal Medicine. ABFM®️ is a registered trademark of the American Board of Family Medicine. None of the trademark holders mentioned are affiliated with AMBOSS.